The expression of cdc-2 and cyclin B1 was reduced after re-expression of RASSF10 in RKO and HCT116 cells (Fig. 3B), providing a mechanism by which RASSF10 induces G2/M arrest in colorectal cancer. Here, RASSF10 is linked to colorectal cancer.